abbvie glp 1 gets into obesity with $350M deal for once-weekly shot AbbVie's GLP-1 challenger shows early

Morton JI, Lazzarini PA, Shaw JE, Magliano DJ (2022) Trends in the incidence of hospitalization for major diabetes-related complications in people with type 1 and type 2 diabetes in Australia, 20102019

Therapeutic Targeting of the NRF2 and KEAP1 Partnership in Chronic Diseases

Oracle AI Medical Insights, clinical administration of intravenous glutathione for protocols such as preventing chemotherapy-induced toxicity involves a dose of 1.5 g/m administered over a period of 15 minutes

A healthy body can produce enough carnitine but cardiopathics and athletes needs bigger amount of it so they need to take it in as a dietary supplement

False-positive interferences of common urine drug screen immunoassays: a review